Use any attack from Kingdra ex's Basic Pokémon card or Stage 1 Evolution card. (Kingdra ex doesn't have to pay for that attack's Energy cost.)
Does 50 damage plus 20 more damage for each Water Energy attached to Kingdra ex but not used to pay for this attack's Energy cost. You can't add more than 40 damage in this way.
Dragon entered circulation in 2003. Series classification for this set is EX.
Set size is 100 cards, which categorizes Dragon as mid-size. As of 2026, the set is 23 years old and fits a legacy-era profile.
Within this set, Kingdra ex is card number 92 with a Rare Holo EX designation.
Kingdra ex is a Dragon card from the 2003 release window. Its card type is Pokémon.
The rarity label is Rare Holo EX. Printed HP is 150.
Energy typing is Water. This gives collectors a clear identity footprint for the print.
As an evolution, Kingdra ex develops from Seadra. The card text reads: When Pokémon-ex has been Knocked Out, your opponent takes 2 Prize cards.
Kingdra ex from Dragon is currently trading around $77.12. Its 7-day movement is largely flat at 0.0%.
Current pricing is broadly aligned with its 30-day average ($76.96). The 90-day window shows a floor near $75.59 and a peak around $77.12 (2% total spread), which maps to low-volatility movement.
Rarity classification for this copy is Rare Holo EX.
Other Kingdra printings create a useful comparison set for Kingdra ex. This comparison sample includes 3 alternatives across 2 sets.
In this sample, pricing ranges between $0.73 and $69.18 (9377% total span). Relative to the alternative average ($24.26), this card is +218%.
Notable alternatives include Kingdra ex #131 (Scarlet & Violet Black Star Promos) at $69.18, Kingdra ex #80 (Shrouded Fable) at $2.88, and Kingdra ex #12 (Shrouded Fable) at $0.73.
Market structure summary: The latest week is near flat (0.0%), suggesting consolidation rather than breakout behavior. Observed 90-day bounds of $75.59 and $77.12 create a 2% band, matching a low-volatility profile.
Relative to the 30-day baseline ($76.96), pricing is near equilibrium. Condition sensitivity is substantial: PSA 10 carries a +1826% premium over raw value.
PSA 9 is currently around $186.38, while PSA 10 is $1485.31.
